1
|
Moretto S, Saita A, Scoffone CM, Talso M, Somani BK, Traxer O, Angerri O, Knoll T, Liatsikos E, Herrmann TRW, Ulvik Ø, Skolarikos A, Cracco CM, Keller EX, Paciotti M, Piccolini A, Uleri A, Tailly T, Carmignani L, Pietropaolo A, Corrales M, Lughezzani G, Lazzeri M, Fasulo V, De Coninck V, Arena P, Nagele U, Ferretti S, Kronenberg P, Perez-Fentes D, Osther PJ, Goumas IK, Acquati P, Ajayi L, Diana P, Casale P, Buffi NM. Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis. World J Urol 2024; 42:234. [PMID: 38613692 DOI: 10.1007/s00345-024-04933-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Accepted: 03/15/2024] [Indexed: 04/15/2024] Open
Abstract
PURPOSE We aimed to accurately determine ureteral stricture (US) rates following urolithiasis treatments and their related risk factors. METHODS We conducted a systematic review and meta-analysis following the PRISMA guidelines using databases from inception to November 2023. Studies were deemed eligible for analysis if they included ≥ 18 years old patients with urinary lithiasis (Patients) who were subjected to endoscopic treatment (Intervention) with ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), or shock wave lithotripsy (SWL) (Comparator) to assess the incidence of US (Outcome) in prospective and retrospective studies (Study design). RESULTS A total of 43 studies were included. The pooled US rate was 1.3% post-SWL and 2.1% post-PCNL. The pooled rate of US post-URS was 1.9% but raised to 2.7% considering the last five years' studies and 4.9% if the stone was impacted. Moreover, the pooled US rate differed if follow-ups were under or over six months. Patients with proximal ureteral stone, preoperative hydronephrosis, intraoperative ureteral perforation, and impacted stones showed higher US risk post-endoscopic intervention with odds ratio of 1.6 (P = 0.05), 2.6 (P = 0.009), 7.1 (P < 0.001), and 7.47 (P = 0.003), respectively. CONCLUSIONS The overall US rate ranges from 0.3 to 4.9%, with an increasing trend in the last few years. It is influenced by type of treatment, stone location and impaction, preoperative hydronephrosis and intraoperative perforation. Future standardized reporting and prospective and more extended follow-up studies might contribute to a better understanding of US risks related to calculi treatment.
Collapse
Affiliation(s)
- S Moretto
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy.
| | - A Saita
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - C M Scoffone
- Department of Urology, Cottolengo Hospital, Turin, Italy
| | - M Talso
- Department of Urology, Luigi Sacco University Hospital, Milan, Italy
| | - B K Somani
- Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK
| | - O Traxer
- Department of Urology, Sorbonne Université, Paris, France
| | - O Angerri
- Department of Urology, Fundació Puigvert Univ. Autonoma de Barcelona, Barcelona, Spain
| | - T Knoll
- Department of Urology, Sindelfingen Medical Center, University of Tübingen, Tübingen, Germany
| | - E Liatsikos
- Department of Urology, University Hospital of Patras, Patras, Greece
| | - T R W Herrmann
- Department of Urology, Spital Thurgau AG, Frauenfeld, Switzerland
- Hannover Medical School, Hannover, Germany
- Division of Urology, Department of Surgical Sciences, Stellenbosch University, Western Cape, South Africa
| | - Ø Ulvik
- Department of Urology, Haukeland University Hospital, Bergen, Norway
| | - A Skolarikos
- Second Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athen, Athens, Greece
| | - C M Cracco
- Department of Urology, Cottolengo Hospital, Turin, Italy
| | - E X Keller
- Department of Urology, University Hospital Zurich, Zurich, Switzerland
| | - M Paciotti
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - A Piccolini
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - A Uleri
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - T Tailly
- Department of Urology, University Hospital Ghent, Ghent, Belgium
| | - L Carmignani
- Department of Urology, University of Milan, Milan, Italy
| | - A Pietropaolo
- Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK
| | - M Corrales
- Department of Urology, Sorbonne Université, Paris, France
| | - G Lughezzani
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - M Lazzeri
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - V Fasulo
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - V De Coninck
- Department of Urology, AZ Klina, Brasschaat, Belgium
| | - P Arena
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - U Nagele
- Department of Urology, General Hospital Hall in Tirol, Hall in Tirol, Austria
| | - S Ferretti
- Department of Urology, Azienda Ospedaliero-Universitaria di Modena, Baggiovara, Italy
| | - P Kronenberg
- Department of Urology, Hospital CUF Descobertas, Lisbon, Portugal
| | - D Perez-Fentes
- Department of Urology, University Hospital Complex of Santiago de Compostela, Santiago, Spain
| | - P J Osther
- Department of Urology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark
| | - I K Goumas
- Department of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy
| | - P Acquati
- Department of Urology, IRCCS Policlinico San Donato, Milan, Italy
| | - L Ajayi
- Department of Urology, Royal Free London NHS Foundation Trust, London, UK
| | - P Diana
- Department of Urology, Fundació Puigvert Univ. Autonoma de Barcelona, Barcelona, Spain
| | - P Casale
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - N M Buffi
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| |
Collapse
|
2
|
Diana P, Esposito S. Epidemiology, risk factors, and prevention strategies of HIV, HPV, and other sexually transmitted infections among cisgender and transgender youth: a narrative review. Front Public Health 2024; 12:1342532. [PMID: 38515602 PMCID: PMC10955097 DOI: 10.3389/fpubh.2024.1342532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 02/26/2024] [Indexed: 03/23/2024] Open
Abstract
Adolescents face an increased risk of contracting sexually transmitted infections (STIs) with alarming data especially concerning HIV. Limited data exists for teenagers regarding the influence of their gender identity (GI) and sexual orientation on the risk of STIs. This narrative review aims to analyse the available data to provide a comprehensive overview of STIs incidence and risk factors among adolescents, taking into account the unique circumstances related to various sexual orientations and GIs. Transgender and gender minority (TGM) youth experience more challenges accessing health services compared to cisgender youth. This is often attributed to non-inclusive health environments, barriers to obtaining medical gender affirmation, and an underestimation of sexual risk perception. Literature analysis has revealed that the majority of adolescents, both cisgender and TGM, have limited awareness regarding the risks associated with their sexual behaviors, the most common sexually transmitted diseases, and strategies for prevention, such as PrEP and HPV vaccination. Moreover, a significant portion of pediatricians possess limited knowledge and comfort in addressing various aspects of sexual health, particularly when it involves discussing topics such as sexual orientation, gender identity, and sexual behaviors with sexually active adolescents. This underscores the pressing need for enhanced education for pediatricians, specifically focusing on STIs diagnosis, prevention, and screening.
Collapse
Affiliation(s)
| | - Susanna Esposito
- Pediatric Clinic, Pietro Barilla Children’s Hospital, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy
| |
Collapse
|
3
|
Schwartzmann I, García Barreras S, D'Anna M, Parejo V, Torneo Ruiz I, Tagalos Muñoz AC, Bravo-Balado A, Diana P, Peri L, Domínguez Esteban M, Fernández Guzmán E. Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up. Actas Urol Esp 2023; 47:668-674. [PMID: 37423384 DOI: 10.1016/j.acuroe.2023.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Accepted: 05/03/2023] [Indexed: 07/11/2023]
Abstract
AIM The aim of this work is to evaluate the initial experience with water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in Spanish university hospitals, as well as to describe the differences in technique and follow-up between centers. MATERIALS AND METHODS This retrospective observational multicenter study collected baseline characteristics, surgical, postoperative and follow-up data at 1, 3, 6, 12 and 24 months, including validated questionnaires, flowmetric variations, complications, and the need for pharmacological or surgical treatment following the procedure. Possible triggers for postoperative acute urinary retention (AUR) were also analyzed. RESULTS A total of 105 patients were included. No differences were observed between the groups with and without AUR with respect to catheterization time (5 and 4.3 days respectively, P=.178), or prostate volume (47.9g and 41.4g respectively, P=.147). The mean improvement at 3, 6, 12 and 24 months in terms of peak flow was 5.3, 5.2, 4.2 and 3.8ml/s, respectively. As for ejaculation, an improvement was observed after 3 months of follow-up and was maintained over time. CONCLUSIONS Minimally invasive treatment for BPH with WVTT shows good functional outcomes at 24 months follow-up, without significant impairment of sexual function and a low incidence of complications. There are minor inter-hospital variations, mainly in the immediate postoperative period.
Collapse
Affiliation(s)
- I Schwartzmann
- Servicio de Urología de la Fundació Puigvert, Barcelona, Spain.
| | | | - M D'Anna
- Servicio de Urología, Hospital Clínic, Barcelona, Spain
| | - V Parejo
- Servicio de Urología, Hospital de Girona Dr. Josep Trueta, Gerona, Spain
| | - I Torneo Ruiz
- Servicio de Urología, Hospital Virgen de la Arrixaca, Murcia, Spain
| | | | - A Bravo-Balado
- Servicio de Urología de la Fundació Puigvert, Barcelona, Spain
| | - P Diana
- Servicio de Urología de la Fundació Puigvert, Barcelona, Spain
| | - L Peri
- Servicio de Urología, Hospital Clínic, Barcelona, Spain
| | - M Domínguez Esteban
- Servicio de Urología, Hospital Universitario Marqués de Valdecillas, Santander, Spain
| | - E Fernández Guzmán
- Servicio de Urología, Hospital Universitario Marqués de Valdecillas, Santander, Spain
| |
Collapse
|
4
|
Andras I, Pecoraro A, Telecan T, Piana A, Boissier R, Hevia V, Prudhomme T, Amparore D, Bertolo R, Carbonara U, Erdem S, Diana P, Ingels A, Kara O, Marandino L, Marchioni M, Muselaers S, Pavan N, Pecoraro A, Roussel E, Crisan N, Territo A, Campi R. How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups. Actas Urol Esp 2023; 47:621-630. [PMID: 37100223 DOI: 10.1016/j.acuroe.2023.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Accepted: 03/13/2023] [Indexed: 04/28/2023]
Abstract
INTRODUCTION Kidney transplant (KT) recipients have a four-times higher risk of renal malignancies compared to general population. As these patients frequently harbor bilateral or multifocal tumors, the management of renal masses is still under debate. OBJECTIVE To explore the current management of the native kidney masses in KT patients. ACQUISITION OF EVIDENCE We performed a literature search on MEDLINE/PubMed database. A number of 34 studies were included in the present review. SYNTHESIS OF EVIDENCE In frail patients with renal masses below 3 cm, active surveillance is a feasible alternative. Nephron-sparing surgery is not justified for masses in the native kidney. Radical nephrectomy is the standard treatment for post-transplant renal tumors of the native kidneys in KT recipients, with laparoscopic techniques leading to significantly less perioperative complication rates as compared to the open approach. Concurrent bilateral native nephrectomy at the time of transplantation can be considered in patients with renal mass and polycystic kidney disease, especially if no residual urinary output is present. Patients with localized disease and successful radical nephrectomy do not require immunosuppression adjustment. In metastatic cases, mTOR agents can ensure efficient antitumoral response, while maintaining proper immunosuppression in order to protect the graft. CONCLUSIONS Post-transplant renal cancer of the native kidneys is a frequent occurrence. Radical nephrectomy is most frequently performed for localized renal masses. A standardized and widely-approved screening strategy for malignancies of native renal units is yet to be implemented.
Collapse
Affiliation(s)
- I Andras
- Servicio de Urología, Universidad de Medicina y Farmacia «Iuliu Hatieganu», Hospital Municipal Cluj-Napoca, Cluj-Napoca, Romania.
| | - A Pecoraro
- Unidad de Cirugía Robótica Urológica y Trasplante Renal, Universidad de Florencia, Hospital de Careggi, Florencia, Italy; Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands
| | - T Telecan
- Servicio de Urología, Universidad de Medicina y Farmacia «Iuliu Hatieganu», Hospital Municipal Cluj-Napoca, Cluj-Napoca, Romania
| | - A Piana
- Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Sección de Urología, Servicio de Oncología, Facultad de Medicina, Hospital San Luigi, Universidad de Turín, Orbassano, Turín, Italy
| | - R Boissier
- Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología y Trasplante Renal, Hospital Universitario La Concepción, Marsella, France
| | - V Hevia
- Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Hospital Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain
| | - T Prudhomme
- Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Trasplante Renal y Andrología, Hospital Universitario de Rangueil, Toulouse, France
| | - D Amparore
- Sección de Urología, Servicio de Oncología, Facultad de Medicina, Hospital San Luigi, Universidad de Turín, Orbassano, Turín, Italy; Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands
| | - R Bertolo
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Hospital San Carlo Di Nancy, Roma, Italy
| | - U Carbonara
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Emergencias y Trasplante de Órganos, Unidad de Urología, Andrología y Trasplante Renal, Universidad de Bari, Bari, Italy
| | - S Erdem
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Sección de Oncología Urológica, Servicio de Urología, Facultad de Medicina de la Universidad de Estambul, Estambul, Turkey
| | - P Diana
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Instituto Clínico y de Investigación Humanitas ICCRS, Rozzano, Italy; Servicio de Urología, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - A Ingels
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, APHP, Hospital Universitario Henri Mondor, Créteil, France
| | - O Kara
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Hospital Universitario Henri Mondor, APHP, Créteil, France
| | - L Marandino
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Oncología Médica, Hospital ICCRS San Raffaele, Universidad Vita-Salute San Raffaele, Milán, Italy
| | - M Marchioni
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Departamento de Ciencias Médicas, Orales y Biotecnológicas, Laboratorio de Biostadística, Universidad «G. D'Annunzio» Chieti-Pescara, Chieti, Italy; Servicio de Urología, Hospital SS Annunziata, Universidad «G. D'Annunzio» de Chieti, Chieti, Italy
| | - S Muselaers
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Centro Médico de la Universidad de Radboud, Nimega, The Netherlands
| | - N Pavan
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Clínica de Urología, Departamento de Ciencias Médicas, Quirúrgicas y de la Salud, Universidad de Trieste, Trieste, Italy
| | - A Pecoraro
- Sección de Urología, Servicio de Oncología, Facultad de Medicina, Hospital San Luigi, Universidad de Turín, Orbassano, Turín, Italy; Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands
| | - E Roussel
- Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Hospital Universitario de Lovaina, Lovaina, Belgium
| | - N Crisan
- Servicio de Urología, Universidad de Medicina y Farmacia «Iuliu Hatieganu», Hospital Municipal Cluj-Napoca, Cluj-Napoca, Romania
| | - A Territo
- Grupo de Trasplante Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Servicio de Urología, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - R Campi
- Unidad de Cirugía Robótica Urológica y Trasplante Renal, Universidad de Florencia, Hospital de Careggi, Florencia, Italy; Grupo de trabajo de Cáncer Renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU), Arnhem, The Netherlands; Departamento de Medicina Experimental y Clínica, Universidad de Florencia, Florencia, Italy
| |
Collapse
|
5
|
Diana P, Saravanakumar S, Sivaganesh D, Sivakumar V, Li Y, Sebastian S, Kim JM, Kannan PK, Sangeetha L, Praneeth VKK. Zinc Silicate Phosphor: Insights of X-Ray Induced and Temperature Enabled Luminescence. LUMINESCENCE 2023; 38:625-636. [PMID: 36929164 DOI: 10.1002/bio.4488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2022] [Revised: 02/19/2023] [Accepted: 03/13/2023] [Indexed: 03/18/2023]
Abstract
The present investigation deals with the effect of calcination temperature on the structural and thermoluminescent (TL) properties of Zn2 SiO4 materials. For this study, Zn2 SiO4 was prepared via a simple hydrothermal route and calcinated at temperatures from 700 °C to 1100 °C in an air atmosphere. TL data of all Zn2 SiO4 samples showed two peaks around 239 °C and 330 °C due to the formation of the luminescence centre during X-ray irradiation. More interestingly, the Zn2 SiO4 sample calcinated at 900 °C exhibited a shift in the TL peak (282 °C and 354 °C) with an optimal TL intensity which is attributed due to its good crystallinity with a well-defined hexagonal plate-like morphology. X-ray irradiated Zn2 SiO4 samples calcinated at 900 °C exhibited a high-temperature TL glow curve peak suggesting that the present material could be used for high-temperature dosimetry applications.
Collapse
Affiliation(s)
- P Diana
- Department of Physics, Kalasalingam Academy of Research and Education, Krishnan Koil, Tamil Nadu, India
| | - Subramanian Saravanakumar
- Department of Physics, Kalasalingam Academy of Research and Education, Krishnan Koil, Tamil Nadu, India
| | - D Sivaganesh
- Department of Physics, Kalasalingam Academy of Research and Education, Krishnan Koil, Tamil Nadu, India.,Ural Federal University, Mira str, Yekaterinburg, Russia
| | - V Sivakumar
- Department of Physics, M. Kumarasamy College of Engineering, Karur, Tamil Nadu, India
| | - Yang Li
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou, Guangdong, China
| | - S Sebastian
- Department of Physics, Arul Anandar College, Karumathur, Madurai, Tamil Nadu, India
| | - Ji-Man Kim
- Department of Chemistry, Sungkyunkwan University, Suwon, The Republic of Korea
| | | | - L Sangeetha
- Department of Physics, Saveetha Engineering College, Chennai, Tamil Nadu, India
| | - Vijayendran K K Praneeth
- Department of Chemistry, Kalasalingam Academy of Research and Education, Krishnan Koil, Tamil Nadu, India
| |
Collapse
|
6
|
Andras I, Pecoraro A, Telecan T, Piana A, Boissier R, Hevia V, Prudhomme T, Amparore D, Bertolo R, Carbonara U, Erdem S, Diana P, Ingels A, Kara O, Marandino L, Marchioni M, Muselaers S, Pavan N, Pecoraro A, Roussel E, Crisan N, Territo A, Campi R. Manejo de masas renales en receptores de trasplante renal. Revisión colaborativa de los grupos de trabajo de trasplante renal y cancer renal de la sección de jóvenes urológos (yau) de la asociación europea de urología (EAU). Actas Urol Esp 2023. [DOI: 10.1016/j.acuro.2023.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
7
|
Frego N, Maffei D, Fasulo V, Paciotti M, Diana P, Avolio P, Chiarelli G, Arena P, Beatrici E, De Carne F, Saita A, Hurle R, Lazzeri M, Casale P, Buffi N, Lughezzani G. Is micro-ultrasound a reliable tool for prostate cancer diagnosis? results from a single-institution cohort of over 1,000 men. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01015-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
8
|
Contieri R, Martini A, Beatrici E, Frego N, Diana P, Paciotti M, Mancon S, Lazzeri M, Saita A, Lughezzani G, Buffi N, Casale P, Kamat A, Hurle R. Implementing the Active Surveillance (AS) follow-up schedule for low-grade Non- Muscle-Invasive Bladder Cancer (NMIBC) tumors. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00657-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
9
|
Paciotti M, Diana P, Gaglioli A, De Groote R, Farinha R, Ficarra V, Gaston R, Gontero P, Hurle R, Martínez-Piñeiro L, Minervini A, Pansadoro V, Van Cleynenbreugel B, Wiklund P, Casale P, Lughezzani G, Mancon S, Uleri A, Mottrie A, Palou J, Gallagher A, Breda A, Buffi N. International experts consensus on performance metrics for a transurethral resection of bladder (TURB). Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01094-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
10
|
Diana P, Gallioli A, Territo A, Rodriguez-Faba Ó, Gaya J, Sanguedolce F, Huguet J, Parada R, Aumatell J, Bravo A, Algaba F, Palou J, Breda A. One year oncological outcome updated analysis of a single-center prospective, randomized, controlled, non-inferiority trial: En bloc vs. conventional transurethral resection of bladder tumor. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00332-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
11
|
Gallioli A, Territo A, Basile G, Diana P, Verri P, Sanguedolce F, Gaya J, Gavrilov P, Uleri A, Fontanet S, Izquierdo P, Huguet J, Algaba F, Palou J, Breda A. The implementation of systematic biopsies in the endoscopic management of upper tract urothelial cancer. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00551-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
12
|
Campi R, Amparore D, Marandino L, Bertolo R, Erdem S, Ingels A, Muselaers S, Pavan N, Roussel E, Carbonara U, Pecoraro A, Diana P, Pecoraro A, Marchioni M. Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00520-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
13
|
Territo A, Verri P, Gallioli A, Uleri A, Basile G, Diana P, Gaya J, Sanguedolce F, Baboudjian M, Hernandez P, Farré A, Algaba F, Arce Y, Palou J, Breda A. Ex vivo confocal microscopy to diagnose upper tract urothelial carcinoma during URS. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01456-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
14
|
De Cassai A, Andreatta G, Diana P, Geraldini F, Pasin L, Salvagno M, Panciera G, Navalesi P, Munari M. Nasal/orotracheal tube switch to reduce length of mechanical ventilation in neurocritical patients: A propensity score matched analysis. Rev Esp Anestesiol Reanim (Engl Ed) 2023; 70:10-16. [PMID: 36621571 DOI: 10.1016/j.redare.2021.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 09/17/2021] [Indexed: 01/07/2023]
Abstract
INTRODUCTION AND OBJECTIVES Nasotracheal intubation was advocated to increase patients comfort and tube tolerance, but no study showed a clear benefit of nasotracheal intubation over orotracheal intubation. Neurocritically ill patients are a fragile group with specific requirements regarding ventilation and sedation. The aim of this study was to evaluate whether nasotracheal intubation might reduce length of mechanical ventilation in neurocritically ill patients. MATERIALS AND METHODS We conducted a retrospective cohort study with propensity matched analysis including all patients who underwent prolonged mechanical ventilation in the neurocritical Intensive Care Unit. RESULTS A total of 4030 patients were admitted during the period of interest and 312 entered the final analysis. Propensity score analysis identified 74 matched couples. Length of mechanical ventilation in patients who underwent early nasotracheal intubation resulted to be statistically significantly shorter than patients who underwent orotracheal intubation. Accordingly, length of sedation was significantly lower in patients with nasotracheal intubation, while no difference in complications occurred with similar length of stay. CONCLUSIONS In critical care units using nasotracheal intubation in the standard management of patients, the nasotracheal route was associated with lesser need for sedatives leading to shorter mechanical ventilation in neurocritical patients. However, causality has to be proven by future randomized controlled trials.
Collapse
Affiliation(s)
- A De Cassai
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy.
| | - G Andreatta
- Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - P Diana
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy
| | - F Geraldini
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy
| | - L Pasin
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy
| | - M Salvagno
- Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - G Panciera
- Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - P Navalesi
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy; Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - M Munari
- UOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, Padua, Italy
| |
Collapse
|
15
|
Garofano G, Diana P, Saitta C, Uleri A, Lughezzani G, Beatrici E, Chiarelli G, Frego N, Contieri R, Paciotti M, Fasulo V, Lazzeri M, Saita A, Hurle R, Casale P, Guazzoni G, Buffi N. The role of Mayo Adhesive Probability score in operative outcomes: A single center prospective analysis. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02548-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
16
|
Diana P, Garofano G, Uleri A, Lughezzani G, Beatrici E, Saitta C, Chiarelli G, Frego N, Paciotti M, Fasulo V, Lazzeri M, Saita A, Hurle R, Casale P, Guazzoni G, Buffi N. Adherent perinephric fat as predictor of post-operative functional recovery after robot-assisted partial nephrectomy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02561-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
17
|
Saitta C, Diana P, Lughezzani G, Casale P, Uleri A, Beatrici E, Chiarelli G, Garofano G, Fasulo V, Avolio P, Lazzeri M, Hurle R, Saita A, Giorgio G, Buffi N. Renal cell carcinoma with venous thrombus: A retrospective single center surgical and oncological analysis. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02550-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
18
|
Avolio P, Fasuolo V, Paciotti M, Diana P, Frego N, Maffei D, Contieri R, Uleri A, Saitta C, Beatrici E, Chiarelli G, De Carne F, Hurle R, Lazzeri M, Saita A, Casale P, Buffi N, Lughezzani G. Assessing the role of high-resolution micro-ultrasound among patients with a negative multiparametric MRI and persistent suspicion of prostate cancer. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01288-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
19
|
Uleri A, Paciotti M, Diana P, Amparore D, Lughezzani G, Casale P, De Naeyer G, De Groote R, Sarchi L, Bravi C, Piramide F, Busacca G, Mottaran A, Mottrie A, Porpiglia F, Buffi N. Techniques and outcomes of robot-assisted partial nephrectomy for the treatment of multiple ipsilateral renal masses. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02226-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
20
|
Garofano G, Diana P, Uleri A, Lughezzani G, Beatrici E, Saitta C, Frego N, Paciotti M, Contieri R, Lazzeri M, Saita A, Hurle R, Guazzoni G, Buffi N. The relationship between adherent perinephric fat and the mayo adhesive probability (MAP) score and post-operative functional outcomes in patients subjected to robot-assisted partial nephrectomy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01188-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
21
|
Diana P, Gaya J, Rodriguez-Faba Ó, Gallioli A, Breda A, Palou J. Enucleation of Complex Renal Masses: Tips and tricks. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02227-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
22
|
Diana P, Territo A, Gaya J, Gavrilov P, Verri P, Bravo-Balando A, Fontanet S, Palou J, Breda A. Robotic-assisted partial nephrectomy with the HUGO RAS system. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02237-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
23
|
Maffei D, Saitta C, Avolio P, Fasulo V, Paciotti M, Frego N, Diana P, Lazzeri M, Hurle R, Saita A, Guazzoni G, Casale P, Buffi N, Lughezzani G. Diagnostic performance of micro-ultrasound guided reclassification biopsies in patients under active surveillance for prostate cancer. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01139-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
24
|
Gallioli A, Diana P, Fontana M, Territo A, Piana A, Verri P, Algaba F, Rodriguez-Faba Ó, Rosales A, Gaya J, Sanguedolce F, Palou J, Breda A. En-bloc versus conventional transurethral resection of bladder tumors: single-center prospective randomized trial. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01223-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
25
|
Beatrici E, Uleri A, Diana P, Saitta C, Chiarelli G, Arena P, Gobbo A, Fasulo V, Avolio P, D’Antuono F, Poretti D, Pedicini V, Lazzeri M, Saita A, Hurle R, Lughezzani G, Guazzoni G, Buffi N. Percutaneous microwave ablation may represent an effective treatment in selected patients with clinical T1 renal masses: a single-institutional experience. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01051-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
26
|
Verri P, Uleri A, Diana P, Baboudjian M, Gaya J, Rodriguez-Faba O, Gallioli A, Huguet J, Bravo A, Aumatell J, Breda A, Palou J. Challenging robotic-assisted radical cystectomy in patient with history of radical prostatectomy and radiotherapy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02225-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Verri P, Baboudjian M, Diana P, Gallioli A, Territo A, Gaya J, Huguet J, Rodriguez-Faba O, Palou J, Breda A. Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis. Actas Urológicas Españolas (English Edition) 2022; 47:4-14. [PMID: 37078844 DOI: 10.1016/j.acuroe.2022.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 06/26/2022] [Indexed: 10/16/2022]
Abstract
OBJECTIVE To assess the oncologic outcomes and the safety profile of a reduced-dose versus full-dose BCG regimen in patients with non-muscle-invasive bladder cancer (NMIBC). MATERIAL AND METHODS We performed a systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The PubMed, Embase, and Web of Science databases were searched in January 2022 for studies that analyzed oncological outcomes and compared between reduced- and full-dose BCG regimens. RESULTS Seventeen studies including 3757 patients met our inclusion criteria. Patients who received reduced-dose BCG had significantly higher recurrence rates (OR 1.19; 95%CI, 1.03-1.36; p = 0.02). The risks of progression to muscle-invasive BC (OR 1.04; 95%CI, 0.83-1.32; p = 0.71), metastasis (OR 0.82; 95%CI, 0.55-1.22; p = 0.32), death from BC (OR 0.80; 95%CI, 0.57-1.14; p = 0.22), and all-cause death (OR 0.82; 95%CI, 0.53-1.27; p = 0.37) were not statistically different. When restricting the analyses to randomized controlled trials, we found similar results. In subgroup analysis, reduced dose was associated with a higher rate of BC recurrence in studies that used only an induction regimen (OR 1.70; 95%CI, 1.19-2.42; p = 0.004), but not when a maintenance regimen was used (OR 1.07; 95%CI, 0.96-1.29; p = 0.17). Regarding side effects, the reduced-dose BCG regimen was associated with fewer episodes of fever (p = 0.003), and therapy discontinuation (p = 0.03). CONCLUSION This review found no association between BCG dose and BC progression, metastasis, and mortality. There was an association between reduced dose and BC recurrence, which was no longer significant when a maintenance regimen was used. In times of BCG shortage, reduced-dose regimens could be offered to BC patients.
Collapse
|
28
|
Frego N, Contieri R, Maffei D, Fasulo V, Uleri A, Beatrici E, Diana P, Lazzeri M, Saita A, Lughezzani G, Buffi N, Casale P, Hurle R. Prognostic risk factors of grade and stage migration in patients under active surveillance: A prospective cohort study from Bladder cancer Italian Active Surveillance register (BIAS). Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00314-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Piana A, Gallioli A, Diana P, Territo A, Gaya J, Gavrilov P, Rodriguez Faba Ó, Huguet J, Guirado L, Facundo C, Campi R, Bellin A, Amparore D, Serni S, Palou J, Porpiglia F, Breda A. 3D Augmented reality-guided robotic-assisted kidney transplantation: Revealing the concealed. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01361-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
30
|
Beatrici E, Contieri R, Frego N, Fasulo V, Diana P, Paciotti M, Saitta C, Chiarelli G, Arena P, Gobbo A, Avolio P, Uleri A, Buffi N, Lazzeri M, Casale P, Saita A, Guazzoni G, Lughezzani G, Hurle R. The update from Bladder Cancer Italian Active Surveillance (BIAS) project for low-grade bladder tumors: Long-term oncological outcomes of patients under active surveillance. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00313-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
31
|
Uleri A, Diana P, Beatrici E, Lughezzani G, Poretti D, D'Antuono F, Lazzeri M, Hurle R, Saita A, Casale P, Contieri R, Fasulo V, Pedicini V, Buffi N. Developing of a novel nephrometry score to predict the outcomes of percutaneous ablation of renal masses: The PCT score. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00301-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
32
|
Avolio P, Fasulo V, Paciotti M, Frego N, Diana P, Maffei D, Contieri R, Uleri A, Beatrici E, Saitta C, Saita A, Lazzeri M, Hurle R, Casale P, Buffi N, Lughezzani G. Assessing the role of high-resolution micro-ultrasound among patients with a negative multiparametric MRI and a persistent suspicion of prostate cancer. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00831-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
33
|
Piana A, Gaya Sopena J, Diana P, Gallioli A, Rosales A, Gavrilov P, Palou J, Breda A. Robotic-assisted inguinal lymphadenectomy for penile cancer: Step-by-step technique. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)02280-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
34
|
Diana P, Breda A, Territo A, Gallioli A, Piana A, Gaya J, Gavrilov P, Desender L, Van Parys B, Van Praet C, Khene Z, Dang V, Doumerc N, Decaestecker K. Intracorporeal versus extracorporeal robot-assisted kidney auto transplantation: Experience of the ERUS RAKT working group. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)02272-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
35
|
Maffei D, Paciotti M, Avolio P, Frego N, Diana P, Fasulo V, Uleri A, Contieri R, Hurle R, Lazzeri M, Saita A, Casale P, Guazzoni G, Buffi N, Lughezzani G. Prostate biopsies by micro-ultrasound for clinically significant cancer detection: Results from a high-volume center. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03095-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
36
|
Piana A, Diana P, Gallioli A, Gaya J, Territo A, Gavrilov P, Palou J, Breda A. Robotic retroperitoneal partial nephrectomy in T1a, T1b, T2 renal tumor. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)02296-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
37
|
Paciotti M, Fasulo V, Lazzeri M, Contieri R, Casale P, Avolio P, Saita A, Lughezzani G, Diana P, Frego N, Saitta C, Guazzoni G, Buffi N, Hurle R. Xpert bladder monitor may avoid cystoscopies in patients under “active surveillance” for recurrent bladder cancer (BIAS project): longitudinal cohort study. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00936-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
38
|
Chiarelli G, Maffei D, Avolio P, Paciotti M, Benevento S, Frego N, Diana P, Fasulo V, Colombo P, Lazzeri M, Hurle R, Saita A, Casale P, Guazzoni G, Buffi N. Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with MPMRI. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00915-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
39
|
Contieri R, Frego N, Paciotti M, Diana P, Beatrici E, Avolio P, Uleri A, Fasulo V, Saita A, Casale P, Buffi N, Lughezzani G, Lazzeri M, Guazzoni G, Hurle R. Active surveillance in low-grade non-muscle-invasive bladder cancers. Results after 8 years of bladder cancer Italian Active Surveillance (BIAS) project. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00703-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
40
|
Sanguedolce F, Gallioli A, Piana A, Diana P, Territo A, Subiela J, Gaya J, Huguet J, Fontana M, Palou J, Breda A. Clinicopathological features, oncological and functional outcomes in patients underwent simultaneous radical cystectomy and nephroureterectomy in panurothelial carcinoma context. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00858-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
41
|
Contieri R, Paciotti M, Frego N, Maffei D, Avolio P, Diana P, Uleri A, Fasulo V, Domanico L, Gobbo A, Lazzeri M, Saita A, Taverna G, Greco F, Muto G, Barra S, Casale P, Lughezzani G, Buffi N, Guazzoni G, Hurle R. Is it safe to replace retur in T1 high grade non-muscle invasive bladder cancer patients with urine cytology and in-office cystoscopy? Preliminary results from the ongoing prospective multicenter trial “hunire”. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00941-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
42
|
Gaya J, Piana A, Gallioli A, Diana P, Territo A, Rosales A, Gavrilov P, Breda A. Organ-sparing surgery with bracka’s reconstruction for penile cancer: a single-center experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00924-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
43
|
Frego N, Avolio P, Paciotti M, Diana P, Contieri R, Uleri A, Maffei D, Fasulo V, Saita A, Buffi N, Casale P, Lughezzani G. One-year follow-up results following transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00712-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
44
|
Piana A, Gallioli A, Diana P, Subiela J, Faba OR, Aumatell J, Esquinas C, Huguet J, Fontana M, Algaba F, Palou J, Breda A. Long-term oncological outcomes of bladder carcinoma in situ (CIS) treated with BCG immunotherapy: prognostic implications of 6-month pathological response assessed by a propensity score matching analysis. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00707-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
45
|
Territo A, Piana A, Fontana M, Gallioli A, Diana P, Gaya J, Huguet J, Gavrilov P, Faba OR, Mottrie A, Molas CF, Guirado L, Palou J, Breda A. Step-by-step development of a cold ischemia device for open and robot-assisted renal transplantation. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00834-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
46
|
Fontana M, Diana P, Territo A, Gallioli A, Piana A, Mercadé A, Fontanet S, Algaba F, Rodriguez-Faba Ó, Gaya Sopena J, Palou J, Breda A. En-bloc versus conventional transurethral resection of bladder tumors: Interim analysis of a single-center prospective randomized trial. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01134-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
47
|
Territo A, Fontana M, Gallioli A, Piana A, Diana P, Gaya J, Huguet J, Gavrilov P, Rodríguez Faba O, Mottrie A, Facundo C, Guirado L, Palou J, Breda A. Step-by-step development of a cold ischemia device for open and robot-assisted renal transplantation. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00728-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
48
|
Uleri A, Diana P, Lughezzani G, Lazzeri M, Casale P, Porpiglia F, Amparore D, Verri P, Rosiello G, Mottrie A, De Naeyerd G, De Grooted R, Porter J, Buffi N. Robot-assisted partial nephrectomy for ruptured angiomyolipomas: A multi institutional series. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01635-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
49
|
Maffei D, Paciotti M, Avolio P, Frego N, Fasulo V, Diana P, Contieri R, Uleri A, Lazzeri M, Hurle R, Saita A, Casale P, Guazzoni G, Buffi N, Lughezzani G. Diagnostic accuracy of mpMRI-US fusion and micro-ultrasound guided biopsies for clinically significant prostate cancer detection. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01300-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
50
|
Piana A, Territo A, Gallioli A, Fontana M, Diana P, Gaya J, Rodríguez Faba O, Huguet J, Gavrilov P, Mercadé A, Subiela J, Guirado L, Facundo C, Bellin A, Amparore D, Palou J, Porpiglia F, Breda A. New technologies in robot-assisted kidney transplantation: Improving surgical performances, expanding the indication. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01623-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|